HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages

被引:59
作者
Basu, Rajatava
Roy, Syamal
Walden, Peter
机构
[1] Humboldt Univ, Dept Dermatol Venerol & Allergol, Charite Univ Med Berlin, Clin Res Grp, D-10117 Berlin, Germany
[2] Indian Inst Chem Biol, Kolkata 700032, W Bengal, India
关键词
D O I
10.1086/513439
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Visceral leishmaniasis is a protozoal disease caused by the intracellular parasites Leishmania donovani and L. chagasi/infantum, and it is usually deadly if not treated. To date, no vaccine exists for prophylaxis or immunotherapy, nor has it been established which effector mechanisms of the immune system are most instrumental against the parasites. Recent reports have suggested that CD8(+) T cells, in addition to CD4(+) T cells, might play major roles in the defense against infection and in the cure of the disease. To identify epitopes recognized by CD8(+) T cells that can be used for immune monitoring to investigate the role of these cells in human visceral leishmaniasis, as well as in vaccine development, we scanned the entire sequence of the leishmanial protein kinetoplastid membrane protein (kmp)-11 with overlapping nonapeptides. Thirty peptides that specifically trigger interferon-gamma secretion by human CD8(+) T cells were identified. Four T cell lines with specificities for different peptides recognize Leishmania-infected autologous macrophages, which proves that kmp-11 is processed and presented via the major histocompatibility complex class I pathway of infected cells. Kmp-11 is thus a candidate antigen for the development of T cell vaccines.
引用
收藏
页码:1373 / 1380
页数:8
相关论文
共 31 条
[1]   T helper (h)1/Th2 and Leishmania:: paradox rather than paradigm [J].
Alexander, J ;
Bryson, K .
IMMUNOLOGY LETTERS, 2005, 99 (01) :17-23
[2]  
Awasthi A, 2004, INDIAN J MED RES, V119, P238
[3]   Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation:: Evidence for mixed Th1-and Th2-like responses in visceral leishmaniasis [J].
Basu, R ;
Bhaumik, S ;
Basu, JM ;
Naskar, K ;
De, T ;
Roy, S .
JOURNAL OF IMMUNOLOGY, 2005, 174 (11) :7160-7171
[4]   CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major [J].
Belkaid, Y ;
Von Stebut, E ;
Mendez, S ;
Lira, R ;
Caler, E ;
Bertholet, S ;
Udey, MC ;
Sacks, D .
JOURNAL OF IMMUNOLOGY, 2002, 168 (08) :3992-4000
[5]   Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells [J].
Bertholet, S ;
Debrabant, A ;
Afrin, F ;
Caler, E ;
Mendez, S ;
Tabbara, KS ;
Belkaid, Y ;
Sacks, DL .
INFECTION AND IMMUNITY, 2005, 73 (10) :6620-6628
[6]  
Bourreau E, 2002, EUR J IMMUNOL, V32, P510, DOI 10.1002/1521-4141(200202)32:2<510::AID-IMMU510>3.0.CO
[7]  
2-4
[8]   Identification of noncanonical melanoma-associated T cell epitopes for cancer immunotherapy [J].
Bredenbeck, A ;
Losch, FO ;
Sharav, T ;
Eichler-Mertens, M ;
Filter, M ;
Givehchi, A ;
Sterry, W ;
Wrede, P ;
Walden, P .
JOURNAL OF IMMUNOLOGY, 2005, 174 (11) :6716-6724
[9]   Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection [J].
Colmenares, M ;
Kima, PE ;
Samoff, E ;
Soong, L ;
McMahon-Pratt, D .
INFECTION AND IMMUNITY, 2003, 71 (06) :3172-3182
[10]   Drug resistance in leishmaniasis [J].
Croft, SL ;
Sundar, S ;
Fairlamb, AH .
CLINICAL MICROBIOLOGY REVIEWS, 2006, 19 (01) :111-+